[1]王宏景.宫颈癌筛查中阴道镜检查阳性与宫颈病理诊断价值比较[J].医学信息,2021,34(15):187-189.[doi:10.3969/j.issn.1006-1959.2021.15.053]
　WANG Hong-jing.Comparison of Positive Colposcopy and Cervical Pathological Diagnosis Value in Cervical Cancer Screening[J].Medical Information,2021,34(15):187-189.[doi:10.3969/j.issn.1006-1959.2021.15.053]
点击复制

宫颈癌筛查中阴道镜检查阳性与宫颈病理诊断价值比较()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年15期
页码:
187-189
栏目:
诊疗技术
出版日期:
2021-08-01

文章信息/Info

Title:
Comparison of Positive Colposcopy and Cervical Pathological Diagnosis Value in Cervical Cancer Screening
文章编号:
1006-1959（2021）15-0187-03
作者:
王宏景
（镇江市丹徒区人民医院病理科，江苏 镇江 212028）
Author(s):
WANG Hong-jing
(Department of Pathology,People’s Hospital of Dantu District,Zhenjiang 212028,Jiangsu,China)
关键词:
宫颈癌; 阴道镜; 宫颈上皮内瘤变; 宫颈癌
Keywords:
Cervical cancer; Colposcopy; Cervical intraepithelial neoplasia; Cervical carcinoma
分类号:
R737.33
DOI:
10.3969/j.issn.1006-1959.2021.15.053
文献标志码:
A
摘要:
目的 比较宫颈癌筛查中阴道镜检查阳性与宫颈病理诊断结果。方法 选取2016年2月~2020年11月在我院接受筛查的50例疑似宫颈癌患者作为研究对象，均给予宫颈病理检测和阴道镜检查，以宫颈病理的检查结果为标准，比较阴道镜检查阳性与宫颈病理诊断价值。结果 以病理检查为金标准，宫颈上皮内瘤变、宫颈癌、宫颈人乳头瘤病毒感染、慢性宫颈黏膜炎、宫颈肌瘤和正常人群的符合率分别为87.50%、80.00%、66.67%，78.95%、66.67%和100.00%；阴道镜检查与宫颈病理诊断检出率比较，差异无统计学意义（P＞0.05）；以宫颈病理诊断结果为金标准，阴道镜与宫颈病理诊断的灵敏度、特异性、阳性预测值、阴性预测值比较，差异无统计学意义（P＞0.05）。结论 阴道镜检查阳性在宫颈癌筛查中具有较准确的诊断辅助宫颈病理检测的优势，具有较高的临床应用价值。
Abstract:
Objective To explore the comparison between positive colposcopy and cervical pathological diagnosis in cervical cancer screening.Methods A total of 50 patients with suspected cervical cancer who were screened in our hospital from February 2016 to November 2020 were selected.All patients were given cervical pathological examination and colposcopy. The results of cervical pathological examination were used as the standard to explore the comparison between positive colposcopy and cervical pathological diagnosis in cervical cancer screening.Results As pathological examination was the gold standard, the coincidence rates of cervical intraepithelial neoplasia, cervical cancer, cervical human papillomavirus infection, chronic cervical mucositis, cervical fibroids and normal population were 87.50%、80.00%、66.67%，78.95%、66.67%和100.00% respectively;There was no statistically significant difference in the detection rate between colposcopy and cervical pathological diagnosis (P>0.05);Taking cervical pathological diagnosis results as the gold standard, there was no statistically significant difference among the sensitivity, specificity, positive predictive value and negative predictive value of colposcopy and cervical pathological diagnosis (P>0.05).Conclusion The positive colposcopy has the advantage of more accurate diagnosis and auxiliary cervical pathological examination in cervical cancer screening, and has high clinical application value.

参考文献/References:

[1]冯树芳,段兆珉,潘正娟,等.HR-HPV TCT检查联合阴道镜定位活组织病理检查在宫颈癌前病变及宫颈癌筛查中的价值[J].医学信息,2016,29(8):124-125. [2]李晓敏.宫颈细胞学检查结合阴道镜检查在宫颈癌筛查中的诊断价值[J].实用妇科内分泌电子杂志,2019,6(34):137. [3]潘翠笠,麦精达,崔色达,等.阴道镜检查在宫颈癌筛查中的价[J].海南医学,2017,28(16):2711-2712. [4]薄素焕,赵淑蕊.液基薄层细胞学检测联合阴道镜LEEP刀在宫颈癌筛查诊治中的应用[J].河北医药,2011,33(11):1644-1646. [5]郭方珍,陶柳,王克兵,等.宫颈癌筛查中阴道镜检查阳性与宫颈病理诊断关系的探讨[J].中国社区医师,2015,36(5):278,281. [6]张晶.HR-HPVTCT分别联合电子阴道镜下宫颈活组织病理检查在宫颈癌前病变及宫颈癌诊断的应用分析[J].中国医疗器械信息,2017,23(15):80-81. [7]柴东明,王征.宫颈癌筛查中阴道镜检查阳性与宫颈病理诊断关系的探讨[J].临床检验杂志(电子版),2019,8(2):170-171. [8]郑玉华.电子阴道镜与病理学检查早期诊断宫颈癌[J].中国基层医药,2004(11):51-52. [9]冯明月,闫萍.宫颈上皮内瘤变诊治现状[J].河北医科大学学报,2020,41(4):480-483. [10]王芳,李全荣,邱琳,等.宫颈高级别上皮内瘤变和宫颈癌患者的TCT和hrHPV结果分析[J].福建医科大学学报,2020,54(6):429-431. [11]易晓芳.宫颈肌瘤诊断与治疗的临床分析[J].中国医药指南,2010,8(6):89-90. [12]侯凤云,石倩茹,李海宁.TCT、HR-HPV检测联合阴道镜下定位活检在宫颈癌前病变筛查中的应用价值[J].宁夏医学杂志,2019,41(3):273-275. [13]于淼淼.宫颈细胞学联合阴道镜及Reid评分诊断宫颈癌前病变的临床价值[J].贵州医药,2016,40(11):1201-1203. [14]章文华,黄蔓妮,李淑梅,等.电子阴道镜与光学阴道镜在宫颈早期病变诊断中的比较研究[J].中华肿瘤杂志,2002,24(6):570,572. [15]梁月容,成燕萍,邵梅华.HPV,TCT筛查结合阴道镜下定位活检对筛查宫颈癌及癌前病变的作用分析[J].中国医药科学,2017,7(4):129-132. [16]言齐,黄文瑾,曾超益,等.HR-HPV、TCT分别联合电子阴道镜下宫颈活检在宫颈癌前病变及宫颈癌诊断中的应用[J].中国当代医药,2016(2):65-67. [17]王秋红,杜桂清,邓桂霞,等.HPV分型联合TCT检测及宫颈活检对宫颈癌癌前病变早期筛查的临床应用分析[J].北京医学,2016,38(1):72-73. [18]卢艳阳,王敬华.宫颈细胞学检查结合阴道镜检查在宫颈癌筛查中的诊断价值[J].中国妇幼保健,2015,30(28):4906-4907.

相似文献/References:

[1]廖加群,曹 雪,陈燕平,等.宫颈癌盆腔淋巴结转移分布及危险因素分析[J].医学信息,2018,31(03):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
　LIAO Jia-qun,CAO Xue,CHEN Yan-ping,et al.Distribution and Risk Factors of Pelvic Lymph Node Metastasis in Cervical Cancer[J].Medical Information,2018,31(15):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
[2]徐 洁.宫颈癌筛查及预防的研究进展[J].医学信息,2018,31(09):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
　XU Jie.Advances in Screening and Prevention of Cervical Cancer[J].Medical Information,2018,31(15):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
[3]黄 花,徐冬冬,章丽霞.TGF-β1在宫颈癌中的研究进展[J].医学信息,2018,31(12):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
　HUANG Hua,XU Dong-dong,ZHANG Li-xia.Research Progress of TGF-β1 in Cervical Cancer[J].Medical Information,2018,31(15):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
[4]夏易曼娜,李虎成.腹腔镜下宫颈癌根治术与传统开腹手术的对比研究[J].医学信息,2018,31(12):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
　XIA Yi-manna,LI Hu-cheng.Comparative Study of Laparoscopic Radical Resection of Cervical Cancer and Traditional Open Surgery[J].Medical Information,2018,31(15):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
[5]杨 军,王翠平,李 龙,等.义安区体检HPV-DNA筛查结果分析[J].医学信息,2018,31(14):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
　YANG Jun,WANG Cui-ping,LI Long,et al.Analysis of the Results of HPV-DNA Screening in the Medical Examination of Yian District[J].Medical Information,2018,31(15):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
[6]王双英,张 娜,刘 芳.具有高危复发因素的早期宫颈癌术后辅助治疗进展[J].医学信息,2018,31(15):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
　WANG Shuang-ying,ZHANG Na,LIU Fang.Advances in Postoperative Adjuvant Therapy for Early Cervical Cancer with High Risk of Recurrence[J].Medical Information,2018,31(15):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
[7]聂小凤,翟慧慧,冷天艳,等.宫颈脱落细胞miR34a检测在HR-HPV阳性患者 分流中的作用分析[J].医学信息,2018,31(16):43.[doi:10.3969/j.issn.1006-1959.2018.16.012]
　NIE Xiao-feng,ZHAI Hui-hui,LENG Tian-yan,et al.Analysis of the Role of MiR34a in Cervical Exfoliated Cells in Shunt of HR-HPV Positive Patients[J].Medical Information,2018,31(15):43.[doi:10.3969/j.issn.1006-1959.2018.16.012]
[8]吴晓玲,周桂华.miR-187在宫颈癌中的表达与临床病理关系的研究[J].医学信息,2018,31(16):69.[doi:10.3969/j.issn.1006-1959.2018.16.019]
　WU Xiao-ling,ZHOU Gui-hua.Expression of miR-187 in Cervical Cancer and Its Relationship with Clinicopathological Features[J].Medical Information,2018,31(15):69.[doi:10.3969/j.issn.1006-1959.2018.16.019]
[9]夏为书,彭莉贞,钟清玲.我国宫颈癌患者配偶生活质量评价的研究现状[J].医学信息,2018,31(23):41.[doi:10.3969/j.issn.1006-1959.2018.23.012]
　XIA Wei-shu,PENG Li-zhen,ZHONG Qing-ling.Research Status of Spouse Quality of Life Evaluation of Cervical Cancer Patients in China[J].Medical Information,2018,31(15):41.[doi:10.3969/j.issn.1006-1959.2018.23.012]
[10]邢 均.全身麻醉联合硬膜外麻醉在宫颈癌手术中的应用及效果评价[J].医学信息,2019,32(01):122.[doi:10.3969/j.issn.1006-1959.2019.01.037]
　XING Jun.Application and Evaluation of General Anesthesia Combined with Epidural Anesthesia in[J].Medical Information,2019,32(15):122.[doi:10.3969/j.issn.1006-1959.2019.01.037]
[11]见永康,吴泽俊,庄雅丽.宫颈癌筛查联合阴道镜活检防治宫颈癌前病变的价值研究[J].医学信息,2023,36(16):117.[doi:10.3969/j.issn.1006-1959.2023.16.022]
　JIAN Yong-kang,WU Ze-jun,ZHUANG Ya-li.Study on the Value of Cervical Cancer Screening Combined with Colposcopy Biopsy in the Prevention and Treatment of Cervical Precancerous Lesions[J].Medical Information,2023,36(15):117.[doi:10.3969/j.issn.1006-1959.2023.16.022]

更新日期/Last Update: 1900-01-01